High serum fibroblast growth factor 21 levels were related to the prognosis and ventricular remodeling of heart failure patients with mildly reduced and reduced ejection fraction.

Fan, Liuzhang; Gu, Lingyun; Yao, Yuyu; Ma, Genshan

Fan, Liuzhang; Gu, Lingyun; Yao, Yuyu; Ma, Genshan.

Afiliação

Fan L; Department of Cardiology, Zhongda Hospital, 162752Medical School of Southeast University, Nanjing, China.
Gu L; Department of Cardiology, Yancheng First Hospital, Affiliated Hospital of Nanjing University Medical School, Yancheng, China.
Yao Y; Department of Cardiology, Zhongda Hospital, 162752Medical School of Southeast University, Nanjing, China.
Ma G; Department of Cardiology, Zhongda Hospital, 162752Medical School of Southeast University, Nanjing, China.

Perfusion ; : 2676591221137482, 2022 Nov 02.

Article em En | MEDLINE | ID: mdl-36321746

Palavras-chave

fibroblast growth factor; fibroblast growth factor 21; heart failure patients with mildly reduced ejection fraction or heart failure patients with mildly reduced; heart failure patients with reduced ejection fraction or reduced ejection fraction; mortality; ventricular remodeling

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article